1 |
3 – Review Action Items |
Further discuss TPUU identification for all ready prepared items, especially for dangerous
drugs. |
DoHA |
2 |
4 – PharmCIS Go-Live |
AMT implementation in PBS XML: provide advice on progress |
DoHA |
3 |
4 – PharmCIS Go- Live) |
Consider the timeliness of AMT releases and the inclusion of AMT information. |
DoHA |
4 |
4 – PharmCIS Go- Live) |
Provide feedback to software vendors regarding the Alphabetic Issue with drug AMT
listing. |
NEHTA |
5 |
4 – PharmCIS Go- Live) |
Clarify business rules for start dates and publish on the PBS website. |
DoHA |
6 |
4 – PharmCIS Go- Live) |
Transition of start dates, provide list of the drugs and date change. |
DoHA |
7 |
6 – Late Changes |
Improvement of the change explanations provided monthly for the PBS schedule. Explanations
should be easy to understand, include the summary and the element of the change. |
DoHA |
8 |
6 – Late Changes |
Develop formal process to deal with Retrospective changes. |
DoHA |
9 |
9 – Future Development |
Provide comments and concerns with current processes for PharmCIS. |
Software Vendors |